Incidence of Ventricular Fibrillation in WPW Syndrome
The incidence of sudden cardiac death from ventricular fibrillation in patients with Wolff-Parkinson-White syndrome ranges from 0.15% to 0.39% over 3-10 years of follow-up, translating to approximately 0-0.6% per patient-year 1.
Key Epidemiologic Data
The most authoritative guideline data comes from the ACC/AHA/ESC consensus, which provides specific population-based evidence 2:
- Annual incidence: 0-0.6% per year for sudden death in WPW patients
- Population study data: In Olmsted County, Minnesota, only 2 sudden deaths occurred over 1,338 patient-years of follow-up among WPW patients
- First presentation: Cardiac arrest is unusual as the first manifestation of WPW, but when it does occur, approximately 50% of cardiac arrest cases represent the first clinical presentation of the syndrome 1
Mechanism and Context
Ventricular fibrillation in WPW occurs when atrial fibrillation develops and conducts rapidly through an accessory pathway with a short refractory period, degenerating into VF 2. While this complication is "feared but infrequent" according to guidelines 2, it represents the most serious mortality risk in this population.
Contemporary Data from Pediatric Populations
More recent research provides additional perspective 3:
- In a large pediatric cohort of 446 WPW patients, 6 sudden deaths occurred (1.3% overall mortality)
- Incidence in structurally normal hearts: 1.1 per 1,000 patient-years
- Incidence with associated heart disease: 27 per 1,000 patient-years (significantly higher, p<0.01)
High-Risk Features for VF
Patients at increased risk for ventricular fibrillation include those with 1:
- Shortest pre-excited R-R interval <250 ms during spontaneous or induced AF
- History of symptomatic tachycardia
- Multiple accessory pathways
- Ebstein's anomaly
- Familial WPW (exceedingly rare but high-risk)
Clinical Implications
The relatively low but non-negligible incidence (0.15-0.6% annually) supports aggressive risk stratification and consideration of catheter ablation in symptomatic patients, particularly those with documented AF, syncope, or short accessory pathway refractory periods 2. The risk is substantially higher in patients with structural heart disease, approaching 2.7% annually 3.
The incidence of AF itself in WPW patients ranges from 15% over 10 years 4 to up to 50% in some series 5, 6, with approximately 12.8% of WPW patients presenting specifically with AF and rapid ventricular rates 7.